Published in Gene Therapy Weekly, November 13th, 2003
"The control of the infection is an indirect effect of the selective elimination by an engineered virus of infected cells that are the source of the pathogens," explained T. Revilla and coauthors at the University of Kentucky. "Therefore, this engineered virus could greatly compensate for a dysfunctional immune system compromised by AIDS."
"In vitro studies using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.